1. Fischbein A, Thornton JC, Lilis R, Valciukas JA, Bernstein J, Selikoff IJ. Zinc protoporphyrin, blood lead, and clinical symptoms in two occupational groups with low-level exposure to lead. Am J Ind Med 1:391-399, 1980.
2. Fischbein A, Thornton J, Blumberg WE, Bernstein J, Valciukas JA, Moses M, Davidow B, Kaul B, Sirota M. Selikoff I. Health status of cable splicers with low-level exposure to lead: Results of a clinical survey. Am J Public Health 70:697-700, 1980.
3. Fischbein A, Thornton J, Wolff MS, Bernstein J, Selikoff IJ. Dermatological findings in capacitor manufacturing workers exposed to dielectric fluids containing polychlorinated biphenyls (PCBs). Arch Environ Health 37:69-74, 1982.
4. Salz J, Lee T, Jester J, Villasenor R, Steel D, Bernstein J, Smith R. Analysis of incision depth following experimental radial keratotomy. Ophthalmology 90:655-659, 1983.
5. Azen S, Hurt A, Steel D, Wilson J, Reinig J, Bernstein J, Bedi M, Smith R. Effects of the shearing posterior intraocular lens on the corneal endothelium. Am J Ophthalmol 95:798-802, 1983.
6. Salz J, Azen S, Bernstein J, Caroline P, Villasenor R, Schanzlin D. Evaluation and comparison of sources of variability in the measurement of corneal thickness with ultrasonic and optical pachymeters. Ophthalmic Surg 14:750-754, 1983.
7. Kilburn K, Warshaw R, Einstein K, Bernstein J. Evidence for air-way disease in non-smoking asbestos workers. Arch Environ Health 40:293-5, 1985.
8. Miller A, Thornton J, Bernstein J, Selikoff I, Tierstein A. Mean and instantaneous expiratory flows, FVC and FEV1: Prediction equations for non-smokers and smokers from a probability sample of Michigan, a large industrial state. Bull Eur Physiopathol Respir 22:589-597, 1986.
9. Weinberger S, Kandall S, Doberczak T, Thornton J, Bernstein J. Early weight change patterns in neonatal abstinence. Am J Dis Child 140:829-832, 1986.
10. Penefsky Z, Wolfe J, Greengard O, Bernstein J. Mechanical responses of developing Fisher rat heart. Effects of Steroid Hormone. J Dev Physiol 8:333-335, 1986.
11. Packer M, Lee WH, Kessler PD, Gottlieb SS, Bernstein JL, Kukin ML. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation 75(5 pt 2):IV80-92, 1987.
12. Packer M, Lee WH, Medina N, Yushak M, Bernstein J, Kessler PD. Prognostic importance of the immediate hemodynamic response to nifedipine in patients with severe left ventricular dysfunction. J Am Coll Cardiol 10:1303-11, 1987.
13. Doberczak T, Thornton J, Bernstein J, Kandall S. Impact of maternal drug dependency on birth weight and head circumference of offspring. Am J Dis Child 141:1163-1167, 1987.
14. Lebovitz A, Byrne M, Bernstein J, Strain J. Chronic occupational exposure to asbestos: More than medical effects? J Occ Med 30:49-50, 1988.
15. Gottlieb SS, Baruch L, Kukin ML, Bernstein J, Fisher ML, Packer M. Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J Am Coll Cardiol 16:827-31, 1990.
16. Bernstein JL, Thompson WD, Risch N, Holford TR. The genetic epidemiology of second primary breast cancer. Am J Epidemiol 136:937-48, 1992.
17. Bernstein JL, Thompson WD, Risch N, Holford TR. Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol 136:925-36, 1992.
18. Dubrow R, Bernstein J, Holford T. Age-period-cohort modelling of large bowel cancer incidence by anatomic subsite and sex in Connecticut. Int J Cancer 53:907-13, 1993.
19. Taioli E, Zhitkovitch A, Toniolo P, Bernstein J, Blum R, Costa M. DNA-protein crosslinks as a biomarker of cis-platinum activity in cancer patients. Oncol Rep 3:439-4, 1996.
20. Tartter PI, Pace D, Frost M, Bernstein JL. Delay in diagnosis of breast cancer. Ann Surg 229:91-6, 1999.
21. Gammon M, Hibshoosh H, Terry MB, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD. Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women. Cancer Epidemiol Biomarkers Prev 8:255-263, 1999.
22. Gammon M, Hibshoosh H, Terry M, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women. Cancer Epidemiol Biomarkers Prev 8:413-9, 1999.
23. Rosenstein BS, Phelps RG, Weinstock MA, Bernstein JL, Gordon ML, Kantor I, Lebwohl MG, Rudikoff D, Shelton R, Lebwohl MG. p53 mutations in basal cell carcinomas arising in routine users of sunscreens. Photochemistry and Photobiology 70:798-806, 1999.
24. Bernstein J, Lopez-Carillo L, Wang L. Epidemiology of HER-2/neu and p53 in breast cancer. Salud Publica Mex 41 Suppl 2: S114-23, 1999.
25. Drumea K, Levine E, Bernstein J, Shank B, Green S, Kaplan E, Mandell L, Cropley J, Obropta J, Braccia I, Krupnik A, Rosenstein B. ATM heterozygosity and breast cancer: screening of 37 breast cancer patients for ATM mutations using a non-isotopic RNase cleavage-based assay. Breast Cancer Res Treat 61:79-85, 2000.
26. Gajdos C, Tartter PI, Bleiweiss IJ, Lopchinsky RA, Bernstein JL. The consequence of undertreating breast cancer in the elderly. J Am Coll Surg 196:698-707, 2001.
27. Atencio DP, Iannuzzi CM, Green S, Stock RG, Bernstein JL, Rosenstein BS. "Screening breast cancer patients for ATM mutations and polymorphisms using denaturing high performance liquid chromatography." Environ Mol Mutagen 38:200-208, 2001.
28. Bernstein JL, Seminara D, Børresen-Dale, A-L. Workshop on The Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002. Breast Cancer Res, 4:249-252, 2002.
29. Bernstein JL, Thompson WD, Casey G, DiCioccio RA, Whittemore AS, Diep AT, Thakore SS, Vaziri S, Xue S, Haile RW. Comparison of techniques for the successful detection of BRCA1 mutations in fixed paraffin-embedded tissue. Cancer Epidemiol Biomarkers Prev. 11(9): 809-14, 2002.
30. Britton JA, Kushi L, Morabia A, Bernstein JL, Shore R, Geringer W, Rohan T. The development of a questionnaire to assess past year physical activity in a multi-ethnic/racial urban population. Soc and Prev Med. 47(3): 178-194, 2002.
31. Bernstein JL, Lapinski R, Lynch CF, Holford T, Thompson WD. Factors influencing mortality among young women with second primary breast cancer. Cancer. 95(10): 2051-8, 2002.
32. Bernstein JL, Teraoka S, Haile RW, Borreson-Dale AL, Rosenstein BS, Diep A, Atencio D, Teitelbaum S, Thompson WD, Bernstein L, Anton-Culver H, Malone K, Lynch CF, Boice Jr. JD, Gatti RA, Langholz BM, Olsen JH, Stovall M, Thomas D, Concannon PJ. Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. Hum Mutat 21(5):542-500, May 2003.
33. Bernstein JL, Lapinski, RH, Thakore SS, Doucette J, Thompson WD. The descriptive epidemiology of second primary breast cancer. Epidemiology. 14(5):552-558, Sept 2003.
34. Bernstein JL, Bernstein L, Thompson WD, Teitelbaum SL, Lynch CF, Boice JD Jr., Rosenstein BS, Børresen-Dale A-L, Gatti RA, Concannon PJ, Haile RW, and the WECARE Study Collaborative Group. ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer. Br J Cancer. 89(8): 1513-1516, Oct 2003.
35. Bernstein JL, Langholz BM, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch CF, Olsen JH, Anton-Culver H, Shore RE, Boice Jr. JD, Berkowitz GS, Gatti RA, Teitelbaum SL, Smith SA, Rosenstein BS, Borresen-Dale, AL, Concannon P, Thompson WD. Research Design: Evaluating gene-environment interactions in the etiology of breast cancer - the WECARE Study. Breast Cancer Res. 6:R199-R214, 2004.
36. Cesaretti JA, Stock RG, Lehrer S, Atencio DA, Bernstein JL, Stone NN, Wallenstein S, Green S, Loeb K, Kollmeier M, Smith M, Rosenstein BS. ATM Sequence Variants are Predictive of Adverse Radiotherapy Response Among Patients Treated for Prostate Cancer. Int J Radiat Oncol Biol Phys 2005;61:196-202.
37. Ioannidis JPA, Bernstein J, Boffetta P, Danesh J, Dolan S, Hartge P, Hunter D, Inskip P, Jarvelin MR, Little J, Maraganore DM, Bishop JA, O'Brien TR, Petersen G, Riboli E, Seminara D, Taioli E, Uitterlinden AB, Vineis P, Winn DM, Salanti G, Higgins JP, Khoury MJ. et al. A network of investigator networks in human genome epidemiology. Am J Epidemiol. 2005 Aug 15;162(4): 302-4.
38. Bernstein JL, Godbold J, Raptis G, Watson M, Levinson B, Aaronson SA, Fleming TP. Identification of mammaglobin as a novel serum marker for breast cancer. Clin Ca Res 11 (18):6528-35, 2005.
39. Bernstein JL, Concannon P, Langholz B, Thompson WD, Bernstein L, Stovall M, Thomas DC;WECARE Study Collaborative Group. Multi-center screening of mutations in the ATM gene among women with breast cancer - the WECARE Study. Radiat Res. 2005 Jun;163(6):698-9.
40. Bernstein JL, Teraoka SN, John EM, Andrulis IL, Knight JA, Lapinski R, Olson ER, Wolitzer AL, Seminara D, Whittemore AS, Concannon P. The CHEK2*1100delC allelic variant and risk of breast cancer: screening results from the breast cancer family registry. Cancer Epidemiol Biomarkers Prev 15(2):348-52, 2006.
41. Langholz B, Bernstein JL, Bernstein L, Olsen JH, Borresen-Dale AL, Rosenstein BS, Gatti RA, Concannon P. On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer. Int J Cancer Feb 22, (Online Publication) 2006.
42. Ioannidis JPA, Gwinn M, Little J, Higgins JPT, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA,Casas Jp, Chokkalingam A, Danesh J, Smith GD, Dolan S, Duncan R, Gruis NA, Hartge P, Hashibe M, Hunter Dj, Jarvelin Mr, Malmer B, Maraganore DM, Newton-Bishop JA, O'Brien TR, Petersen G, Riboli E, Salanti G, Seminara D, Smeeth L, Taioli E, timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Khoury MJ. Human Genome Epidemiology Network and the Network of Investigator Networks. A road map for efficient and reliable human genome epidemiology. Nat. Genet. Jan; 38(1): 3-5, 2006.
43. Goldfrank D, Chuai S, Bernstein JL, y Cajal TR, Lee JB, Alonso MC, Diez O, Baiget M, Kauff ND, Offit K, Robson M. Impact of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2. Cancer Epidemiol Biomarkers Prev (in press).
44. Seminara D, Khoury MJ, O'Brien TR, Gwinn ML, Little J, Higgins JPT, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE…Ioannidis JPA. The emergence of networks in human genome epidemiology: Challenges and opportunities. Epidemiology (in press).
45. Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer AL, Whittemore AS, West D, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, Giles GG, Hopper JL, Concannon P. Population-based estimates of breast cancer risk associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry. Hum Mutat 2006 (11):1122-8
